News & Media

Play
Slider

AMR News

COVID-19 COVERAGE

For all media requests, please contact AMR Marketing Director Jaime Farra at jaime.farra@amrllc.com.  

FEATURED STORIES: 

WSFL TV – June 24, 2020 – AMR Miami General Manager Scott Rosen discusses employment and volunteer opportunities during the COVID pandemic.

WKRB CBS News – June 4, 2020 – Kathy Welch, Coastal Clinical Research founder – now AMR Mobile, and Lauren Garner, AMR Mobile General Manager, are interviewed regarding upcoming COVID-19 Investigational Studies at their Mobile, Alabama research center.

WBIR NBC News – April 23, 2020 – Dr. William Smith, AMR CEO, was interviewed regarding upcoming COVID-19 clinical studies to come to AMR Knoxville and other AMR locations over the next few months.

NBC Nightly News – April 23, 2020 – COVID-19 vaccine volunteer Mike was interviewed by NBC about why he volunteered for AMR Kansas City’s COVID-19 Vaccine Clinical Study.

KCTV Channel 5 Kansas City – April 6, 2020 – Dr. John Ervin discussed the importance of our COVID-19 Vaccine Clinical Trial today with Abby Dodge.

Associated Press – April 8, 2020 – AP interviews Dr. John Ervin, AMR Kansas City, regarding the COVID-19 Vaccine Clinical Trial after Ervin administers second trial vaccine to volunteer.

OTHER STORIES:

KSN NBC Channel 3 – Dr. Terry Klein, a principal investigator at AMR Wichita East and one of Heartland Research Associates’ founders, was interviewed regarding a Phase II COVID-19 Investigational Vaccine Clinical Study that recently started at AMR Newton.

WKTY ABC – April 27, 2020 – WKTY in Lexington, Kentucky interviewed Dr. Mark S. Adams regarding the center’s Phase I COVID-19 Vaccine recently awarded to their clinical research center.

ESPN Sports Radio Lexington – April 26, 2020 – Dr. Mark S. Adams spoke with ESPN Sports talkshow hosts about AMR Lexington’s Phase I COVID-19 Vaccine Clinical Study.  The center was originally chosen as a back-up site but then was awarded the study.  Screenings and enrollment begin the first week of June 2020.

KAKE ABC News – May 20, 2020 – Dr. Richard Glover, AMR Newton, was interviewed about the center’s Phase II COVID-19 Vaccine Clinical Study.

Radio.com 97.1 FM – April 11, 2020 – St. Louis, MO.  Dr. William Smith, AMR CEO, was featured on Radio.com / 97.1 FM in Missouri regarding AMR Kansas City’s COVID-19 Vaccine Clinical Research Trial.

KY 3 NBC News – April 10, 2020 – Springfield, MO news team discusses the COVID-19 Vaccine itself, how it works and how it is different than a flu vaccine.

Fox News – April 9, 2020 – Fox News covers COVID-19 Vaccine Clinical Trial.

NBC News – April 9, 2020 – NBC News interviews Dr. John Ervin, AMR Kansas City, and volunteer Mike.

New York Times – April 8, 2020 – NYTimes discusses AMR Kansas City’s involvement in the Inovio Clinical Trial for the COVID-19 Vaccine.

Fox 4 Kansas City – April 7, 2020

“Years from now, this pandemic will be in history books. We are in an historic moment and how effectively we respond will be forever memorialized. That is why the Center for Pharmaceutical Research, an AMR company, is honored to work with Inovio to bring a COVID-19 vaccine to market through clinical research. Our entire team is committed to the urgency and importance of this clinical trial. Now more than ever, the world is waiting and will witness the enormous value of clinical research.”
~ John E. Ervin, MD, Principal Investigator, The Center for Pharmaceutical Research, an AMR company

KCTV Channel 5 Kansas City – April 6, 2020 – Dr. John Ervin discussed the importance of our COVID-19 Vaccine Clinical Trial today with Abby Dodge.
ESPN Radio Lexington – April 6, 2020 – Dr. Mark S. Adams, AMR Lexington, is interviewed about COVID-19 and being selected as a backup clinical trial site.
KMBC Channel 9 Kansas City – April 3, 2020 –  Dr. John Ervin and the team at CPR would like to thank KMBC 9 for this story!
KAKE News 10 Wichita, KS – March 23, 2020 – Dr. Terry Poling discussing possible Coronavirus Clinical Research Trials coming to AMR.
ABC News – March 22, 2020 – ABC News talks with Inovio about their COVID-19 Vaccine Clinical Trial that they have teamed up with AMR KC to conduct.

 

AMR COVID-19 PRESS RELEASE

AMR – Keeping Research Going
Friday, April 10, 2020

In these extraordinary times, it is more evident than ever the impact that clinical research has on each of us and on our global community. That is why AMR locations nationwide have decided to continue enrolling for clinical research studies with much thought and care.   

Our volunteers’ health and safety during a clinical research study is always our primary concern, as well as the health of our site visitors such as sponsors and CROs. To protect our patients, clients, employees and families, we are taking additional safety precautions as highlighted on our website homepage at www.amrllc.com.  Please also view our video at https://youtu.be/Otwen8JAtRw.

We also want you to know that, as we protect our staff, we have made scheduling adjustments.  AMR sites are accepting new studies and continue to serve you with the excellence you expect from our AMR team. In fact, during these challenging times, we are more confident than ever in our ability to meet your clinical research needs.

In the midst of the pandemic, we were able to randomize 741 healthy volunteers into a vaccine study in five weeks, seven weeks ahead of schedule.  Originally, seven AMR centers were allotted 93 subjects each. However, a center outside of AMR was unable to contribute to the study. Those subjects were allocated to AMR and we successfully enrolled the additional subjects at our AMR Las Vegas, AMR Knoxville and AMR Norfolk locations.  

Now more than ever, advancements in clinical research are crucial and AMR is here to support your clinical development plans. Whether directly related to COVID-19 or other important medical conditions, our team is at the ready to support your clinical research site needs.

Thank you for working with us during this time, and please be assured that we will continue our efforts to ensure safety for all while moving forward with our work.  

We are in this.  Together.

 

AMR Donates to Local Non-Profit Organizations

(Knoxville, Tennessee – April 2019)  Alliance for Multispecialty Research held a company-wide competition – AMRch Madness – during March 2019.  Each location selected a local non-profit organization and staff members made weekly donations for that non-profit org.  A total of $4,736.36 was raised company-wide.